A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
NCT03760666
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
17
Enrollment
INDUSTRY
Sponsor class
Stopped
No efficacy observed, COVID-19 caused sites to shut down
Conditions
Acute Myeloid Leukemia
Interventions
DRUG:
Brequinar/Brequinar + Ribavirin
Sponsor
Clear Creek Bio, Inc.